<DOC>
	<DOC>NCT02959112</DOC>
	<brief_summary>Endoscopic retrograde cholangiopancreatography (ERCP) complications occur in 5 to 10% of cases, post ERCP pancreatitis is the most common, it is a complication with significant morbidity, occasional mortality and high costs. In the prevention of post-ERCP pancreatitis have been used various treatments, NSAIDs and pancreatic stent are the most useful, however, despite its use, post ERCP pancreatitis continues to affect 10 to 15% of patients with high risk. Epinephrine sprayed on the papilla may decrease the edema and prevent the development of this complication.</brief_summary>
	<brief_title>Epinephrine Sprayed on the Papilla Versus Sterile Water Sprayed on the Papilla for Preventing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography</brief_title>
	<detailed_description />
	<mesh_term>Pancreatitis</mesh_term>
	<mesh_term>Indomethacin</mesh_term>
	<mesh_term>Epinephrine</mesh_term>
	<mesh_term>Racepinephrine</mesh_term>
	<mesh_term>Epinephryl borate</mesh_term>
	<criteria>Age 18 years or older Patient with an indication for endoscopic retrograde cholangiopancreatography Patient without prior endoscopic retrograde cholangiopancreatography Patient who accept contact by telephone Previous sphincterotomy Allergy to epinephrine or indomethacin NSAIDs use in the prior week Pancreatic cancer located in the head Chronic pancreatitis Renal failure (Cr &gt;1.4 mg / dl) Indication for endotracheal intubation independent of endoscopic retrograde cholangiopancreatography Biliodigestive derivation Pregnant patients</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>pancreatitis after ERCP</keyword>
	<keyword>epinephrine</keyword>
	<keyword>papilla</keyword>
	<keyword>rectal indomethacin</keyword>
</DOC>